Q-omics provides the consensus-scored PRSS50 profile across patient tissues and cancer cell-line models.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for PRSS50 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with PRSS50 in patient tissues and cancer cell lines. In cancer cell lines, PRSS50 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in PANCREAS, while CRISPR and shRNA rows add functional-dependency signals in URINARY_TRACT and LUNG_NSCLC_LUAD.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼CRISPR
CRISPR	2,042	PANCREAS (236)	view →
RNA	1,430	URINARY_TRACT (176)	view →
▼RNA
RNA	2,998	LUNG_NSCLC_LUAD (690)	view →
Function (RNA)	946	LUNG_NSCLC_LUAD (230)	view →
▼Mutation
Mutation	2,579	BLOOD_Leukemia (1415)	view →
RNA	26	BLOOD_Leukemia (23)	view →
▼shRNA
RNA	1,897	LUNG_SCLC (303)	view →
shRNA	1,707	LUNG_SCLC (159)	view →